8.52084
Fmoc-Dab(ivDde)-OH
Novabiochem®
Manufacturer: Sigma Aldrich
CAS Number: 607366-21-2
Synonym(S): Fmoc-Dab(ivDde)-OH, N-α-Fmoc-N-γ-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)-3-methylbutyl-L-diaminobutanoic acid
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 1 G | 8.52084-1-G | In Stock | ₹ 18,590.00 |
| 5 G | 8.52084-5-G | In Stock | ₹ 69,933.58 |
8.52084 - 1 G
In Stock
Quantity
1
Base Price: ₹ 18,590.00
GST (18%): ₹ 3,346.20
Total Price: ₹ 21,936.20
Quality Level
200
product line
Novabiochem®
Assay
≥95.0% (HPLC)≥98% (TLC)
form
powder
reaction suitability
reaction type: Fmoc solid-phase peptide synthesis
manufacturer/tradename
Novabiochem®
application(s)
peptide synthesis
functional group
amine
storage temp.
15-25°C
InChI
1S/C32H38N2O6/c1-19(2)15-26(29-27(35)16-32(3,4)17-28(29)36)33-14-13-25(30(37)38)34-31(39)40-18-24-22-11-7-5-9-20(22)21-10-6-8-12-23(21)24/h5-12,19,24-25,35H,13-18H2,1-4H3,(H,34,39)(H,37,38)/t25-/m0/s1
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | Chem-Impex International, Inc. Na-Fmoc-Ng-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)-3-methylbutyl-L-2,4-diaminobutyric acid | 607366-21-2 | MFCD01631660 | 5G | -- | ₹ 88,921.65 | |
| | STA PHARMACEUTICAL US LLC WuXi TIDES Fmoc-L-Dab(ivDde)-OH | 607366-21-2, 25GR | -- | ₹ 44,559.65 | |
| | STA PHARMACEUTICAL US LLC WuXi TIDES Fmoc-L-Dab(ivDde)-OH | 607366-21-2, 50GR | -- | ₹ 79,759.03 | |
| | STA PHARMACEUTICAL US LLC WuXi TIDES Fmoc-L-Dab(ivDde)-OH | 607366-21-2, 1GR | -- | ₹ 4,192.44 | |
| | STA PHARMACEUTICAL US LLC WuXi TIDES Fmoc-L-Dab(ivDde)-OH | 607366-21-2, 100GR | -- | ₹ 1,48,008.53 | |
| | (2S)-4-[[1-(4,4-Dimethyl-2,6-dioxocyclohexylidene)-3-methylbutyl]amino]-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]butanoic acid | -- | ₹ 342.24 - ₹ 16,256.40 | |
| | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-((1-(4,4-dimethyl-2,6-dioxocyclohexylidene)-3-methylbutyl)amino)butanoic acid | -- | ₹ 3,764.64 - ₹ 17,026.44 | |
| | 607366-21-2 | Fmoc-dab(ivdde)-oh | -- | ₹ 2,909.04 - ₹ 1,93,451.16 |
Related Products
Description
- General description: This orthogonally-protected diaminobutyric acid derivative is based on the hindered Dde variant ivDde. The side-chain ivDde group is considerably more stable to piperidine than Dde and is less prone to migrate from protected to unprotected side-chains [1] and from side-chain to γ-amino group [2].When removing ivDde in the presence of allyl-based protecting groups, allyl alcohol should be included in the deprotection solution to prevent reduction of the allyl group [3]. Associated Protocols and Technical ArticlesCleavage and Deprotection Protocols for Fmoc SPPSLiterature references[1] S. R. Chhabra, et al. (1998) Tetrahedron Lett., 39, 1603. [2] R. Wilhelm, personal communication. [3] B. Rohwedder, et al. (1998) Tetrahedron Lett., 39, 1175. [4] S. K. Sharma, et al. (1999) J. Peptide Res., 53, 501.
- Linkage: Replaces: 04-12-1196
- Analysis Note: Colour (visual): white to slight yellow to beigeAppearance of substance (visual): powderIdentity (IR): passes testEnantiomeric purity: ≥ 99.5 % (a/a)Purity (TLC(157A)): ≥ 98 %Purity (TLC(157B)): ≥ 98 %Assay (HPLC, area%): ≥ 95.0 % (a/a)Solubility (1 mmole in 2 ml DMF): clearly solubleWater (K. F.): ≤ 1.00 %To see the solvent systems used for TLC of Novabiochem® products please click here.
- Legal Information: Novabiochem is a registered trademark of Merck KGaA, Darmstadt, Germany
SAFETY INFORMATION
Storage Class Code
11 - Combustible Solids
WGK
WGK 2
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable